Role of Selective Sodium-Glucose Co-Transporter-2 Inhibitors in Managing Cardio-Renal Complications in Type 2 Diabetes Mellitus: Beyond Glycemic Control.

Onyali, Chike B; Anim-Koranteng, Comfort; Shah, Hira E; Bhawnani, Nitin; Ethirajulu, Aarthi; Alkasabera, Almothana; Mostafa, Jihan A

Onyali, Chike B; Anim-Koranteng, Comfort; Shah, Hira E; Bhawnani, Nitin; Ethirajulu, Aarthi; Alkasabera, Almothana; Mostafa, Jihan A.

Afiliación

Onyali CB; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Anim-Koranteng C; Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Shah HE; Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Bhawnani N; Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Ethirajulu A; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Alkasabera A; General Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Mostafa JA; Psychiatry/Cognitive Behavioural Psychotherapy, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Cureus ; 13(8): e17452, 2021 Aug.

Article en En | MEDLINE | ID: mdl-34603858

Palabras clave

cardio vascular disease; chronic kidney disease (ckd); diabetes mellitus type 2; human pathophysiology; pharmacology; sglt2; sodium-glucose co-transporter 2 inhibitor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Aspecto: Patient_preference Idioma: En Revista: Cureus Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google